Analyst Price Targets — RNTX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 3, 2025 6:02 pm | Kemp Dolliver | Loop Capital Markets | $6.00 | $1.75 | StreetInsider | Brookline Capital Markets Upgrades Rein Therapeutics (RNTX) to Buy |
Latest News for RNTX
Shares of Rein Therapeutics Inc. (NASDAQ: RNTX - Get Free Report) traded up 1.6% during trading on Friday. The stock traded as high as $1.3451 and last traded at $1.30. 44,298 shares changed hands during trading, a decline of 51% from the average session volume of 90,560 shares. The stock had previously closed at $1.28.
Rein Therapeutics Inc. (NASDAQ: RNTX - Get Free Report)'s stock price traded down 0.8% during mid-day trading on Thursday. The company traded as low as $1.22 and last traded at $1.22. 52,502 shares were traded during trading, a decline of 78% from the average session volume of 237,899 shares. The stock had previously closed at
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for RNTX.
U.S. House Trading
No House trades found for RNTX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.